Delivery Order SPE2DB22D3401-SPE2DB25FT2BM
Award Date 2/13/25
Potential Completion Date 2/14/25
Potential Value $1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Imatinib Mesylate 400 mg tablets, a medication used to treat certain types of cancer. The contract has a ceiling value of $1,871.93 and a completion date of June 11, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,139,158 units of Imatinib Mesylate 400 mg tablets in 30-count packages, with a ceiling value of $1,179.42. The contract is a firm-fixed-price, non-set-aside contract type with a performance period through May 6, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with...
- This federal contract award, valued at $4,087.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Imatinib Mesylate 100 mg tablets, a medication used to treat certain types of cancer. The contract is a Firm Fixed Price Delivery Order with a completion date of January 6, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency awarded a delivery order valued at $1,024.44 to AmerisourceBergen Drug Corp for Imatinib Mesylate 400 mg tablets (30-count supply) on December 9, 2025, with an ultimate completion date of December 10, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a primary pharmaceutical distributor for federal medical procurement...
- This federal contract award, with ID SPE2DX15D1053|SPE2DX24F6JDQ, is for the delivery of 4,563,971,891 units of Imatinib Mesylate 400 mg tablets in packages of 30. The contract has a firm fixed price of $1,416.39 and an ultimate completion date of March 15, 2024. The award was made on March 14, 2024 to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. doing business as Amerisourcebergen. The contract was awarded by the Defense Logistics Agency...
- The Defense Logistics Agency awarded a $47,123.25 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Imatinib Mesylate 400 mg tablets (30-count packages), with a completion date of June 2, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, to be performed at the vendor's Conshohocken, Pennsylvania location. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The $2,233.75 firm fixed price delivery order is for the supply of 4,563,970,506 units of Imatinib Mesylate 400 mg tablets. The award has a period of performance through March 15, 2024 and does not have a set-aside designation. This delivery order is issued under an Indefinite Delivery Contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,242.05 Firm Fixed Price Delivery Order is for the supply of 4,558,265,473 units of Imatinib Mesylate 100 mg tablets. The contract has an ultimate completion date of August 30, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,141.83 firm fixed-price delivery order is for the supply of 4,559,069,294 units of Imatinib Mesylate 400mg tablets. The award has an ultimate completion date of November 14, 2022 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- This delivery order for $242 from the Defense Logistics Agency to Amerisourcebergen Drug Corp is for 400 mg tablets of Imatinib Mesylate. The order is for 30 tablets and is a firm fixed price contract with performance in Conshohocken, Pennsylvania. The completion date is October 20, 2023. No set-aside designation was used for this order, which is associated with the Defense Logistics Agency's mission to provide logistics support for the Department of Defense and foreign military partners.